Assessing the susceptibility of 200 Rhipicephalus microplus populations to fluralaner using larval immersion test: A nationwide analysis from Brazil
Authors:
- Haile Dean Figueiredo ChagasHCHaile Dean Figueiredo Chagas
- Arthur Matos de SantanaASArthur Matos de Santana
- Gabriel Webert GomesGGGabriel Webert Gomes
- Ana Carolinne Lopes AscençãoAAAna Carolinne Lopes Ascenção
- Emanuel Magalhães SouzaESEmanuel Magalhães Souza
- Laura Cristina Ferreira FariaLFLaura Cristina Ferreira Faria
- Mayara Macedo BarrozoMBMayara Macedo Barrozo
- Ana Lucia Coutinho TeixeiraATAna Lucia Coutinho Teixeira
- Daniel de Castro RodriguesDRDaniel de Castro Rodrigues
- Fernando de Almeida BorgesFBFernando de Almeida Borges
- Lívio Martins Costa-JuniorLCLívio Martins Costa-Junior
- Lorena Lopes FerreiraLFLorena Lopes Ferreira
Open Access
- 16 April 2026
- journal article
- research article
- Published by Springer Nature in Parasites & Vectors
- Vol. 19 (1)
Abstract
Background: In 2022, a tick control product, against Rhipicephalus microplus , containing fluralaner as the active ingredient was initially launched in the Brazilian market, followed by other markets across Latin America. Once a new molecule is introduced for the control of a parasitic organism, it becomes essential to develop methods for assessing the susceptibility of target parasitic populations. In this context, discriminating dose (DD) tests represent a valuable tool. Methods: This study evaluated the susceptibility profile of 200 R. microplus populations originating from 21 federal units (20 states and a federal district) across all five regions of Brazil, using a larval immersion test (LIT) with two discriminating doses (DD) of 1.55 and 3.16 µg/mL. Populations showing mortality rates above 95% were classified as susceptible. A field trial was also conducted with one population (São José do Rio Pardo [SJRP]), which had a known history of exposure to fluralaner, to compare laboratory and field test outcomes. Results: The DD at a concentration of 1.55 µg/mL resulted in 100% mortality in 160 populations (80%), whereas the DD at a concentration of 3.16 µg/mL showed more consistent results, with 100% mortality in 182 populations (91%). In the field trial population, SJRP, fluralaner achieved 100% therapeutic efficacy (days +7 to +21) and persistent efficacy (days +28 to +42). Conclusions: LIT using DDs can provide indicative data on the susceptibility of R. microplus to fluralaner. The discriminating dose at a concentration of 3.16 µg/mL was shown to be the most appropriate for monitoring the susceptibility of R. microplus populations to fluralaner. Laboratory and field data support the classification of the SJRP population as susceptible, demonstrating consistency between the two sets of results. These results can serve as a basis for continuous spatial and temporal monitoring of the susceptibility of R. microplus populations to fluralaner. Continued research, integrating laboratory and field results, is essential to increase the reliability of laboratory-based testing.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Code 001)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (317482/2021-1)
- MSD Animal Health
This publication has 38 references indexed in Scilit:
- Rhipicephalus microplus (Southern cattle tick; Asian blue tick)Trends in Parasitology, 2024
- Acaricide resistance status of livestock ticks from East and West Africa and in vivo efficacy of acaricides to control themInternational Journal for Parasitology: Drugs and Drug Resistance, 2024
- Phenotypic and genotypic characterization of acaricide resistance in Rhipicephalus microplus field isolates from South Africa and BrazilInternational Journal for Parasitology: Drugs and Drug Resistance, 2023
- Selection for, and characterization of, fluralaner resistance in the house fly, Musca domesticaPesticide Biochemistry and Physiology, 2023
- Combination of synthetic acaricides with (E)-cinnamaldehyde to control Rhipicephalus microplusExperimental and Applied Acarology, 2022
- Cross-resistance between macrocyclic lactones in populations of Rhipicephalus microplus in Brazil’s semiarid regionExperimental and Applied Acarology, 2022
- A retrospective review on ixodid tick resistance against synthetic acaricides: implications and perspectives for future resistance prevention and mitigationPesticide Biochemistry and Physiology, 2021
- Resistance of the cattle tick Rhipicephalus (Boophilus) microplus to ivermectin in ArgentinaResearch in Veterinary Science, 2020
- Strategies for the control of Rhipicephalus microplus ticks in a world of conventional acaricide and macrocyclic lactone resistanceParasitology Research, 2017
- A new approach to characterization of the resistance of populations of Rhipicephalus microplus (Acari: Ixodidae) to organophosphate and pyrethroid in the state of Minas Gerais, BrazilExperimental Parasitology, 2013